Unlabelled: PRéCIS:: Ocular surface disease (OSD) in glaucoma is an area for improvement in the management of patients with glaucoma. This study explores the knowledge of glaucoma subspecialists toward OSD in glaucoma, then provides a suggested treatment algorithm.
Purpose: To assess the attitudes, knowledge, and level of comfort of Canadian glaucoma specialists with respect to the assessment and management of OSD among patients with glaucoma.
Methods: Ophthalmologist members of the Canadian Glaucoma Society with fellowship training in glaucoma were contacted to participate in this cross-sectional survey study. Responses were recorded to statements regarding attitudes toward OSD in glaucoma, and assessment and management modalities. These were recorded primarily in the form of a Likert scale rated 1 to 7 from "strongly disagree" to "strongly agree." Descriptive statistics were generated, and mean and SD for responses on Likert scales.
Results: Thirty-six responses were included. All respondents agreed that comprehensive management of OSD could improve quality of life, 97% agreed it could lead to better glaucoma outcomes, whereas only 22% agreed it is presently being adequately managed in glaucoma practices. Respondents were asked to list all treatment modalities they felt knowledgeable about, ranging from 100% for optimizing topical glaucoma therapies to 31% for serum tears. Nearly all respondents (92%) agreed that a suggested algorithm for the treatment of OSD in glaucoma could improve their approach to management.
Conclusion: OSD is a common comorbidity of glaucoma. Although respondents overwhelmingly agreed that comprehensive management of OSD may lead to improved quality of life and glaucoma-related outcomes, only a small percentage felt it was presently adequately managed. Increasing knowledge related to the assessment and management of OSD in glaucoma may in the future improve patient care.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/IJG.0000000000001659 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ocular Surface Disease and Dry Eye Severity in Glaucoma Patients at Urban Private Eye Care Centres in Malaysia.
Clin Ophthalmol
November 2024
Mahkota Medical Centre, Melaka, Malaysia.
Background: Ocular surface disease (OSD) severity varies among glaucoma patients and is exacerbated by intraocular pressure (IOP)-lowering medications.
Purpose: To determine OSD prevalence and dry eye severity among glaucoma patients at nine private clinics in Malaysia.
Methods: This multicentre, cross-sectional observational study recruited glaucoma patients undergoing routine eye examinations, with IOP ≤21mmHg receiving anti-glaucoma eye drops.
Effects of Glaucoma Treatment on Ocular Surface and Tear Functions: Comparison of Trabeculectomy and Antiglaucoma Drops.
Turk J Ophthalmol
October 2024
Mersin University Faculty of Medicine, Department of Ophthalmology, Mersin, Türkiye.
Article Synopsis
- The study aimed to compare tear function and ocular surface disease (OSD) in glaucoma patients treated with medications in one eye and trabeculectomy surgery in the other.
- The researchers analyzed data from 19 patients who had surgery at least six months prior, assessing various eye health indicators compared to a control group of healthy individuals.
- Results indicated that both treatment methods similarly affected OSD, with some improvement noted over time, but neither approach showed a significant advantage over the other regarding the incidence of OSD.
Managing Ocular Surface Disease in Glaucoma Treatment: A Systematic Review.
Bioengineering (Basel)
October 2024
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Ocular surface disease (OSD) is a frequent disabling challenge among patients with glaucoma who use benzalkonium chloride (BAK)-containing topical glaucoma medications for prolonged periods. In this comprehensive review, we evaluated the prevalence of OSD and its management, focusing on both current and future alternatives. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria were used to assess a) the impact of active ingredients and preservatives on the ocular surface and b) the efficacy of preservative-free (PF) alternatives and adjunctive therapies.
View Article and Find Full Text PDFA Comparative Study of Ocular Surface Disease in Childhood Glaucoma.
Cornea
January 2025
Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Article Synopsis
- - The study aimed to assess ocular surface disease (OSD) in children with childhood glaucoma (CG) by comparing 41 eyes from CG patients to 42 eyes from healthy controls.
- - Findings indicated that CG patients had shorter tear break-up time (TBUT) and more severe dry eye disease (DED) symptoms, with higher prevalence of punctate epithelial erosions, particularly influenced by the number of glaucoma medications used.
- - The results highlighted a significant increase in OSD signs and symptoms in CG patients compared to healthy individuals, suggesting the need for further research based on different CG types.
Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.
J Ocul Pharmacol Ther
November 2024
R and R Eye Research, LLC, San Antonio, Texas, USA.
To compare intraocular pressure (IOP), ocular surface disease (OSD) parameters, and safety in patients with open-angle glaucoma (OAG)/ocular hypertension (OH) and concurrent OSD treated with preservative-free latanoprost 0.005% cationic emulsion (PF-latanoprost-E) or travoprost-Z 0.004% ophthalmical solution containing a soft preservative system.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!